Table 2. Details of final histopathological examination report.
| Parameters | ULMS (n = 44) |
LGESS (n = 25) |
HGESS (n = 9) |
OTHERS (n = 7) |
|
|---|---|---|---|---|---|
| Stage | I | 32 (37.6) | 14 (16.5) | 4 (4.7) | 4 (4.7) |
| II | 9 (10.6) | 8 (9.4) | 3 (3.5) | 1 (1.2) | |
| III | 2 (2.4) | 2 (2.4) | 1 (1.2) | 1 (1.2) | |
| IV | 1 (1.2) | 1 (1.2) | 1 (1.2) | 1 (1.2) | |
| Tumor size | <5 cm | 1 (1.2) | 16 (18.8) | 3 (3.5) | 0 (0) |
| >5 cm | 43 (50.6) | 9 (10.6) | 6 (7) | 7 (8.2) | |
| Tumor site | Intramural | 31 (36.5) | 10 (11.8) | 6 (7) | 2 (2.4) |
| Subserosal | 8 (9.4) | 13 (15.3) | 2 (2.4) | 5 (5.9) | |
| Submucosal | 5 (5.9) | 2 (2.4) | 1 (1.2) | 0 (0) | |
| IHC | ER+ PR− | 0 (0) | 5 (5.9) | 1 (1.2) | 0 (0) |
| ER− PR+ | 0 (0) | 1 (1.2) | 1 (1.2) | 0 (0) | |
| Both+ | 0 (0) | 11 (12.9) | 2 (2.4) | 0 (0) | |
| Both− | 0 (0) | 0 (0) | 1 (1.2) | 0 (0) | |
| Not available | 44 (51.8) | 8 (9.4) | 4 (4.7) | 7 (8.2) | |
| Other structures involvement | Ovary | 6 (7.1) | 5 (5.9) | 1 (1.2) | 1 (1.2) |
| Lymph node | 1 (1.2) | 1 (1.2) | 2 (2.4) | 1 (1.2) | |
ER, estrogen receptor; HGESS, high grade endometrial stromal sarcoma; LGESS, low grade endometrial stromal sarcoma; PR, progesterone receptor